ChromaCure

About:

ChromaCure discover and develop first-in-class small molecule therapeutics for unmet needs in oncology.

Top Investors: New Science Ventures, S.R.I.W., Sambrinvest, Theodorus III, Newton Biocapital

Description:

ChromaCure will launch a drug development program to identify potential new candidates that selectively and potently inhibit cancer targets and potentially provide novel therapy for multiple forms of cancer, either as monotherapy or in combination with immunotherapy or chemotherapy.

Total Funding Amount:

17M EUR

Headquarters Location:

Gosselies, Hainaut, Belgium

Founded Date:

2018-01-01

Founders:

Cédric Blanpain

Number of Employees:

1-10

Last Funding Date:

2018-05-29

IPO Status:

Private

Industries: